
November 18, 2017 - By Adrian Erickson

Investors sentiment decreased to 0.95 in 2017 Q2. Its down 0.03, from 0.98 in 2017Q1. It worsened, as 78 investors sold Bristol-Myers Squibb Co shares while 520 reduced holdings. 120 funds opened positions while 451 raised stakes. 1.10 billion shares or 2.26% less from 1.12 billion shares in 2017Q1 were reported.
Swiss State Bank owns 6.11 million shares. Nadler Financial Gp accumulated 6,629 shares or 0.13% of the stock. Coastline Trust accumulated 26,830 shares. Fil Limited has 550,360 shares for 0.09% of their portfolio. Mirae Asset Global Co Ltd holds 0.13% or 136,424 shares. Moreover, Shelton Capital has 0.13% invested in Bristol-Myers Squibb Co (NYSE:BMY). Brick And Kyle Associates holds 53,859 shares. 397,431 were accumulated by Axa. Qci Asset Mgmt Ny owns 231,766 shares. Sands Capital Limited Liability Com has invested 0% in Bristol-Myers Squibb Co (NYSE:BMY). M Incorporated stated it has 19,234 shares. Nj State Employees Deferred Compensation Plan has 26,884 shares for 0.28% of their portfolio. Bridges Invest Mngmt has 0.1% invested in Bristol-Myers Squibb Co (NYSE:BMY). Bailard owns 21,290 shares or 0.09% of their US portfolio. Cwm Ltd Company holds 0.13% in Bristol-Myers Squibb Co (NYSE:BMY) or 46,568 shares. The stock of Bristol Myers Squibb Company (NYSE:BMY) registered a decrease of 21.19% in short interest. BMY’s total short interest was 7.44 million shares in November as published by FINRA. Its down 21.19% from 9.44 million shares, reported previously. With 7.10 million shares average volume, it will take short sellers 1 days to cover their BMY’s short positions.  The stock decreased 0.87% or $0.54 on November 17, reaching $61.32. About 4.15 million shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since November 18, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The company has market cap of $99.47 billion. The Company’s pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. It has a 24.12 P/E ratio. Small molecule drugs are administered orally in the form of a pill or tablet.Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 68 analyst reports since July 28, 2015 according to SRatingsIntel. The stock has “Buy” rating by UBS on Friday, October 6. On Tuesday, June 14 the stock rating was maintained by Jefferies with “Hold”. The firm has “Buy” rating by UBS given on Friday, August 19. The firm has “Sell” rating given on Monday, November 13 by BMO Capital Markets. As per Friday, September 9, the company rating was maintained by Barclays Capital. Citigroup maintained Bristol-Myers Squibb Co (NYSE:BMY) on Wednesday, October 25 with “Buy” rating. The rating was initiated by Robert W. Baird on Wednesday, April 26 with “Outperform”. The rating was maintained by Citigroup on Tuesday, September 20 with “Buy”. Barclays Capital maintained the shares of BMY in report on Friday, October 13 with “Equal-Weight” rating. The firm has “Buy” rating given on Monday, October 30 by SunTrust.More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: Seekingalpha.com which released: “Bristol-Myers Squibb (BMY) Presents at Jefferies 2017 London Healthcare …” on November 15, 2017, also Nasdaq.com with their article: “Bristol-Myers Squibb Co. Reports 8% Decline In Q3 Bottom Line” published on October 26, 2017, Barrons.com published: “Which Will Pfizer Buy? Biogen or Bristol-Myers Squibb” on November 13, 2017. More interesting news about Bristol-Myers Squibb Co (NYSE:BMY) were released by: Nasdaq.com and their article: “Bristol-Myers Says FDA Expands Approval Of Sprycel” published on November 10, 2017 as well as Investorplace.com‘s news article titled: “Rating for Bristol-Myers Squibb Co (BMY) Dropsâ€¦.. Wilting Earnings Visibility” with publication date: November 10, 2017.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
<!-- google_ad_client = "ca-pub-7620071422727774"; /* weeklyregister.com_300x600 */ google_ad_slot = "8032669457/1411802476/1313492366"; google_ad_width = 300; google_ad_height = 600; //-->


